Related references
Note: Only part of the references are listed.Serum Adropin Levels in Patients on Hemodialysis
Dijana Boric-Skaro et al.
LIFE-BASEL (2021)
Primary Sjogren's Syndrome and Cardiovascular Disease
Konstantinos Melissaropoulos et al.
CURRENT VASCULAR PHARMACOLOGY (2020)
Serum adropin levels are reduced in patients with inflammatory bowel diseases
Darko Brnic et al.
SCIENTIFIC REPORTS (2020)
ADROPIN - POTENTIAL LINK IN CARDIOVASCULAR PROTECTION FOR OBESE MALE TYPE 2 DIABETES MELLITUS PATIENTS TREATED WITH LIRAGLUTIDE
Tina Ticinovic Kurir et al.
ACTA CLINICA CROATICA (2020)
Adropin in women with polycystic ovary syndrome
Justyna Kuliczkowska-Plaksej et al.
ENDOKRYNOLOGIA POLSKA (2019)
Adropin Contributes to Anti-Atherosclerosis by Suppressing Monocyte-Endothelial Cell Adhesion and Smooth Muscle Cell Proliferation
Kengo Sato et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Adropin and Inflammation Biomarker Levels in Male Patients With Obstructive Sleep Apnea: A Link With Glucose Metabolism and Sleep Parameters
Josko Bozic et al.
JOURNAL OF CLINICAL SLEEP MEDICINE (2018)
ENHO gene expression and serum adropin level in rheumatoid arthritis and systemic lupus erythematosus
Servet Yolbas et al.
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE (2018)
Adropin is associated with hyperhomocysteine and coronary atherosclerosis
Liang-Ping Zhao et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2016)
Salusins and adropin: New peptides potentially involved in lipid metabolism and atherosclerosis
Leszek Niepolski et al.
ADVANCES IN MEDICAL SCIENCES (2016)
Adropin levels and target organ damage secondary to high blood pressure in the ED
Bedia Gulen et al.
AMERICAN JOURNAL OF EMERGENCY MEDICINE (2016)
A novel peptide adropin in cardiovascular diseases
Liang Li et al.
CLINICA CHIMICA ACTA (2016)
Serum adropin level and ENHO gene expression in systemic sclerosis
Servet Yolbas et al.
CLINICAL RHEUMATOLOGY (2016)
Cardiovascular disease risk burden in primary Sjogren's syndrome: results of a population-based multicentre cohort study
E. Bartoloni et al.
JOURNAL OF INTERNAL MEDICINE (2015)
Inverse Correlation Between Plasma Adropin and ET-1 Levels in Essential Hypertension A Cross-Sectional Study
Xiaosong Gu et al.
MEDICINE (2015)
Prevalence of and Factors Associated With Increased Arterial Stiffness in Patients With Primary Sjogren's Syndrome
Jose Mario Sabio et al.
ARTHRITIS CARE & RESEARCH (2015)
Subclinical atherosclerosis and impaired bone health in patients with primary Sjogren's syndrome: prevalence, clinical and laboratory associations
Fotini Gravani et al.
ARTHRITIS RESEARCH & THERAPY (2015)
THU0320 New Parameters for Identifying Subclinical Atherosclerosis in Patients with Primary SjöGren’s Syndrome: A Pilot Study
F. Atzeni et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Low serum adropin is associated with coronary atherosclerosis in type 2 diabetic and non-diabetic patients
Lingzhen Wu et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2014)
Three new players in energy regulation: Preptin, adropin and irisin
Suleyman Aydin
PEPTIDES (2014)
Serum adropin levels are decreased in patients with acute myocardial infarction
Hou-you Yu et al.
REGULATORY PEPTIDES (2014)
Clinical Course, Prognosis, and Cause of Death in Primary Sjogren's Syndrome
Ildiko Fanny Horvath et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2014)
The epidemiology of Sjogren's syndrome
Ruchika Patel et al.
CLINICAL EPIDEMIOLOGY (2014)
Deficiency of a New Protein Associated with Cardiac Syndrome X; Called Adropin
Ahmet Celik et al.
CARDIOVASCULAR THERAPEUTICS (2013)
Adropin Deficiency Is Associated With Increased Adiposity and Insulin Resistance
K. Ganesh Kumar et al.
OBESITY (2012)
Endothelial Dysfunction in Primary Sjogren Syndrome
A. Akyel et al.
WEST INDIAN MEDICAL JOURNAL (2012)
SignalP 4.0: discriminating signal peptides from transmembrane regions
Thomas Nordahl Petersen et al.
NATURE METHODS (2011)
EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome
Raphaele Seror et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Adropin Is a Novel Regulator of Endothelial Function
Fina Lovren et al.
CIRCULATION (2010)
Cardiovascular risk factors in primary Sjogren's syndrome: a case-control study in 624 patients
M. Perez-De-Lis et al.
LUPUS (2010)
Subclinical atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus
Jane E. Salmon et al.
AMERICAN JOURNAL OF MEDICINE (2008)
Identification of Adropin as a Secreted Factor Linking Dietary Macronutrient Intake with Energy Homeostasis and Lipid Metabolism
K. Ganesh Kumar et al.
CELL METABOLISM (2008)
Soluble form of vascular cell adhesion molecule 1 induces migration and proliferation of vascular smooth muscle cells
Hwan Myung Lee et al.
JOURNAL OF VASCULAR RESEARCH (2008)
Sjogren's syndrome disease damage index and disease activity index - Scoring systems for the assessment of disease damage and disease activity in Sjogren's syndrome, derived from an analysis of a cohort of Italian patients
Claudio Vitali et al.
ARTHRITIS AND RHEUMATISM (2007)
Precocious intima-media thickening in patients with primary Sjogren's syndrome
G Vaudo et al.
ARTHRITIS AND RHEUMATISM (2005)
Accelerated atherosclerosis in autoimmune rheumatic diseases
Y Shoenfeld et al.
CIRCULATION (2005)
Endothelial function testing as a biomarker of vascular disease
S Verma et al.
CIRCULATION (2003)
Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group
C Vitali et al.
ANNALS OF THE RHEUMATIC DISEASES (2002)
Elevated nitric oxide production in patients with primary Sjogren's syndrome
A Wanchu et al.
CLINICAL RHEUMATOLOGY (2000)
Share Paper
